The Sleeping Giant of Data Privacy

Data drives decisions of the worlds largest companies but in a world with constant data, how do you make sense of it? Host TC Riley, puts the world under the lens of data and analytics and explores current news, B2B trends, and popular topics.

 

The price users pay for consumer electronics is usually not the primary source of revenue for those that sell them. What’s most valuable is the data they collect on users. If companies can gather and monetize data, consumers get more affordable prices, and tech companies enjoy large profits. But what happens if data privacy regulations throttle this? Will the economy take a nosedive? On Diving into Data, host TC Riley breaks down the economic consequences of data privacy.

“Consumer data is underrated and isn’t factored into the big economic picture. This data largely subsidizes the cost of consumer electronics,” Riley said.

Consumer data has a high value because it fuels ad revenue on digital channels. To illustrate the value of data, consider Microsoft’s acquisition of LinkedIn and Facebook’s purchase of WhatsApp had nothing to do with the tech and everything to do with the data.

If big tech companies are turned upside down with data privacy regulations, their stocks will tumble, as will the entire market.” – Thomas Riley

Next, Riley offered a refresher on inflation, as it’s another economic force that ties into consumer data value. Riley made this hypothesis. “Inflation is being held artificially low due to the value of consumer data to many companies creating these consumer goods.”

For example, Apple sells an iPhone for $1000 and recoups its money through advertising revenue. The irony is that Apple is championing data privacy with its latest software update.

If data collection restriction becomes the norm, consumer data value will plummet. Should that happen, the economy could be in for a disruption. It may start as Facebook running more ads or no longer being free. Then stock prices fall for big tech, which now makes up around 20% of the S&P.

“If big tech companies are turned upside down with data privacy regulations, their stocks will tumble, as will the entire market. On top of that, consumer goods prices will rise, creating a further tailspin in the market.”

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

personal branding
Personal Branding Now Drives B2B Success, Customer Trust, and Competitive Advantage
December 5, 2025

Personal branding has rapidly shifted from a “nice-to-have” to a strategic imperative in B2B marketing, reshaping how companies communicate, differentiate, and build trust. As industries evolve and professionals take on more dynamic, multi-stream careers, visibility and authenticity have become critical assets. Key findings from the Edelman + LinkedIn Thought Leadership Impact Report show that…

Read More
IT
Real-World IT Practices Are Streamlining AV Deployments and Raising the Bar for Consistency
December 4, 2025

For years, the AV industry has discussed the long-anticipated convergence with IT—but that shift is no longer theoretical. With cloud adoption accelerating, hybrid work normalizing, and organizations rebuilding digital infrastructure after years of rapid change, AV systems now sit squarely on the IT backbone. In fact, the majority of newly upgraded conference rooms require network-centric…

Read More
ROI
ROI Case Study
December 3, 2025

Denials are no longer a slow leak in the revenue cycle—they’re a fast-moving, rule-shifting game controlled by payers, and hospitals that don’t model denial patterns in real time end up budgeting around losses they could have prevented. PayerWatch’s four-digit, client-verified ROI in 2024 shows what happens when a hospital stops reacting claim by…

Read More
coverage
Clip 2 – Fighting for Coverage: One Patient’s Story
December 3, 2025

Health insurers love to advertise themselves as guardians of care, but the real story often begins when a patient’s life no longer fits neatly into a spreadsheet. In oncology especially, “coverage” isn’t a bureaucratic checkbox—it’s the fragile bridge between a treatment that finally works and a relapse that can undo years of grit…

Read More